Mutations in HFE, the most common cause of hereditary hemochromatosis, lead to iron overload. The iron overload is characterized by increased iron uptake due to lower levels of the hepatic, iron regulatory hormone hepcidin. HFE was cloned 21 years ago, but the signaling pathway is still unknown. Because bone morphogenetic protein (BMP) signaling is impaired in patients with hereditary hemochromatosis, and the interaction of HFE and the BMP type I receptor ALK3 was suggested in vitro, in vivo experiments were performed. In vivo, hepatocyte-specific Alk3-deficient and control mice were injected with either AAV2/8-Hfe-Flag or PBS. HFE overexpression in control mice results in increased hepatic hepcidin levels, p-Smad1/5 levels, and iron deficiency anemia, whereas overexpression of HFE in hepatocyte-specific Alk3-deficient mice results in no change in hepcidin, p-Smad1/5 levels, or blood parameters. These results indicate that HFE signals predominantly via ALK3 to induce hepcidin in vivo.

Department of Anesthesiology Intensive Care and Pain Medicine University Hospital Muenster University of Muenster Albert Schweitzer Campus 1 48149 Muenster Germany

Department of Cell Developmental and Cancer Biology Oregon Health and Science University 3181 SW Sam Jackson Park Road Portland OR 97239 USA

Institute of Pathological Physiology 1st Faculty of Medicine Charles University U Nemocnice 5 Prague 128 53 Czech Republic

Zobrazit více v PubMed

Nemeth E, et al. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science. 2004;306:2090–2093. doi: 10.1126/science.1104742. PubMed DOI

Pigeon C, et al. A new mouse liver-specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload. J. Biol. Chem. 2001;276:7811–7819. doi: 10.1074/jbc.M008923200. PubMed DOI

Hentze MW, Muckenthaler MU, Galy B, Camaschella C. Two to tango: regulation of mammalian iron metabolism. Cell. 2010;142:24–38. doi: 10.1016/j.cell.2010.06.028. PubMed DOI

Pietrangelo A. Iron and the liver. Liver Int. 2016;36:116–123. doi: 10.1111/liv.13020. PubMed DOI

Pietrangelo A. Hereditary hemochromatosis: pathogenesis, diagnosis, and treatment. Gastroenterology. 2010;139:393–408. doi: 10.1053/j.gastro.2010.06.013. PubMed DOI

Hollerer I, Bachmann A, Muckenthaler MU. Pathophysiological consequences and benefits of HFE mutations: 20 years of research. Haematologica. 2017;102:809–817. doi: 10.3324/haematol.2016.160432. PubMed DOI PMC

Latour C, et al. Differing impact of the deletion of hemochromatosis-associated molecules HFE and transferrin receptor-2 on the iron phenotype of mice lacking bone morphogenetic protein 6 or hemojuvelin. Hepatology. 2016;63:126–137. doi: 10.1002/hep.28254. PubMed DOI

Feder JN, et al. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat. Genet. 1996;13:399–408. doi: 10.1038/ng0896-399. PubMed DOI

Steinbicker AU, Muckenthaler MU. Out of balance–systemic iron homeostasis in iron-related disorders. Nutrients. 2013;5:3034–3061. doi: 10.3390/nu5083034. PubMed DOI PMC

Feder JN, et al. The hemochromatosis gene product complexes with the transferrin receptor and lowers its affinity for ligand binding. Proc. Natl Acad. Sci. USA. 1998;95:1472–1477. doi: 10.1073/pnas.95.4.1472. PubMed DOI PMC

Schmidt PJ, Toran PT, Giannetti AM, Bjorkman PJ, Andrews NC. The transferrin receptor modulates Hfe-dependent regulation of hepcidin expression. Cell Metab. 2008;7:205–214. doi: 10.1016/j.cmet.2007.11.016. PubMed DOI PMC

Rishi G, Crampton EM, Wallace DF, Subramaniam VN. In situ proximity ligation assays indicate that hemochromatosis proteins Hfe and transferrin receptor 2 (Tfr2) do not interact. PLoS ONE. 2013;8:e77267. doi: 10.1371/journal.pone.0077267. PubMed DOI PMC

Schmidt PJ, Fleming MD. Transgenic HFE-dependent induction of hepcidin in mice does not require transferrin receptor-2. Am. J. Hematol. 2012;87:588–595. doi: 10.1002/ajh.23173. PubMed DOI PMC

Schmidt PJ, Andrews NC, Fleming MD. Hepcidin induction by transgenic overexpression of Hfe does not require the Hfe cytoplasmic tail, but does require hemojuvelin. Blood. 2010;116:5679–5687. doi: 10.1182/blood-2010-04-277954. PubMed DOI PMC

D’Alessio F, Hentze MW, Muckenthaler MU. The hemochromatosis proteins HFE, TfR2, and HJV form a membrane-associated protein complex for hepcidin regulation. J. Hepatol. 2012;57:1052–1060. doi: 10.1016/j.jhep.2012.06.015. PubMed DOI

Kautz L, et al. BMP/Smad signaling is not enhanced in Hfe-deficient mice despite increased Bmp6 expression. Blood. 2009;114:2515–2520. doi: 10.1182/blood-2009-02-206771. PubMed DOI

Wu XG, et al. HFE interacts with the BMP type I receptor ALK3 to regulate hepcidin expression. Blood. 2014;124:1335–1343. doi: 10.1182/blood-2014-01-552281. PubMed DOI PMC

Steinbicker AU, et al. Perturbation of hepcidin expression by BMP type I receptor deletion induces iron overload in mice. Blood. 2011;118:4224–4230. doi: 10.1182/blood-2011-03-339952. PubMed DOI PMC

Gao J, et al. Hepatocyte-targeted HFE and TFR2 control hepcidin expression in mice. Blood. 2010;115:3374–3381. doi: 10.1182/blood-2009-09-245209. PubMed DOI PMC

Corradini E, et al. BMP6 treatment compensates for the molecular defect and ameliorates hemochromatosis in Hfe knockout mice. Gastroenterology. 2010;139:1721–1729. doi: 10.1053/j.gastro.2010.07.044. PubMed DOI PMC

Corradini E, et al. Bone morphogenetic protein signaling is impaired in an HFE knockout mouse model of hemochromatosis. Gastroenterology. 2009;137:1489–1497. doi: 10.1053/j.gastro.2009.06.057. PubMed DOI PMC

Sauer B. Functional expression of the cre-lox site-specific recombination system in the yeast Saccharomyces cerevisiae. Mol. Cell. Biol. 1987;7:2087–2096. doi: 10.1128/MCB.7.6.2087. PubMed DOI PMC

Mishina Y, Hanks MC, Miura S, Tallquist MD, Behringer RR. Generation of Bmpr/Alk3 conditional knockout mice. Genesis. 2002;32:69–72. doi: 10.1002/gene.10038. PubMed DOI

Huang FW, Pinkus JL, Pinkus GS, Fleming MD, Andrews NC. A mouse model of juvenile hemochromatosis. J. Clin. Invest. 2005;115:2187–2191. doi: 10.1172/JCI25049. PubMed DOI PMC

Gurieva I, et al. Erythropoietin administration increases splenic erythroferrone protein content and liver TMPRSS6 protein content in rats. Blood Cells, Mol. Dis. 2017;64:1–7. doi: 10.1016/j.bcmd.2017.02.007. PubMed DOI